Diamond Biotechnology Co., Ltd.(TW:6815)
NT$19.90+0.90 (+4.74%)
TW:6815
Diamond Biotechnology Co., Ltd. financials statements
NT$19.90
At close:+0.90 (+4.74%)
Diamond Biotechnology Co., Ltd. (6815) Income Statement
Diamond Biotechnology Co., Ltd. Income Statement
Last quarter (Q2 2026), Diamond Biotechnology Co., Ltd.'s total revenue was NT$280.74M, a decrease of 27.60% from the same quarter last year. In Q2, Diamond Biotechnology Co., Ltd.'s net income was NT$32.11M. See Diamond Biotechnology Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 501.49M | NT$ 768.25M | NT$ 616.10M | NT$ 434.84M | NT$ 395.20M | |
| NT$ 155.25M | NT$ 330.71M | NT$ 289.59M | NT$ 184.32M | NT$ 187.88M | |
| NT$ 229.44M | NT$ 217.96M | NT$ 190.94M | NT$ 101.45M | NT$ 139.79M | |
| Depreciation and Amortization | NT$ 28.72M | NT$ 28.03M | NT$ 50.31M | NT$ 53.48M | NT$ 58.18M |
| NT$ -45.94M | NT$ 131.16M | NT$ 116.17M | NT$ 99.04M | NT$ 112.72M | |
| NT$ -74.19M | NT$ 112.75M | NT$ 63.91M | NT$ 46.41M | NT$ 48.09M | |
| NT$ -5.65M | NT$ -17.06M | NT$ -5.58M | NT$ -4.40M | NT$ 4.17M | |
| NT$ -79.84M | NT$ 95.69M | NT$ 58.33M | NT$ 41.82M | NT$ 52.05M | |
| NT$ -70.31M | NT$ 73.20M | NT$ 46.74M | NT$ 33.39M | NT$ 41.92M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -1.78 | NT$ 1.90 | NT$ 1.27 | NT$ 1.20 | NT$ 1.51 |
| Diluted EPS | NT$ -1.78 | NT$ 1.90 | NT$ 1.27 | NT$ 1.20 | NT$ 1.51 |
| Weighted Average Shares Outstanding | 39.50M | 31.37M | 31.16M | 27.82M | 27.82M |
| Weighted Average Shares Outstanding (Diluted) | 39.50M | 31.37M | 31.16M | 27.83M | 27.83M |
Currency in TWD
